Accelerate Diagnostics
AXDX
$5.25
Share price
-2.05%
Change (1 day)
191.66%
Change (1 year)
Categories
Accelerate Diagnostics (AXDX) - Cash on Hand
Cash on Hand as of June 2023 : $30.7 M
According to Accelerate Diagnostics's latest financial reports the company has $30.7 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Accelerate Diagnostics - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $45.56 M | -28.38% |
| 2021-12-31 | $63.61 M | -6.81% |
| 2020-12-31 | $68.26 M | -37.05% |
| 2019-12-31 | $0.10 B | -34.86% |
| 2018-12-31 | $0.16 B | 52.51% |
| 2017-12-31 | $0.10 B | 40.38% |
| 2016-12-31 | $77.76 M | -41.28% |
| 2015-12-31 | $0.13 B | 98.6% |
| 2014-12-31 | $66.67 M | 58.8% |
| 2013-12-31 | $41.98 M | |
| 2012-07-31 | $14.26 M | 1738.39% |
| 2011-07-31 | $0.77 M | 173.89% |
| 2010-07-31 | $0.28 M | -67.14% |
| 2009-07-31 | $0.86 M | -30.09% |
| 2008-07-31 | $1.23 M | -11.52% |
| 2007-07-31 | $1.39 M | -53.61% |
| 2006-07-31 | $3 M | -46.01% |
| 2005-07-31 | $5.56 M | -23.08% |
| 2004-07-31 | $7.23 M | -16.97% |
| 2003-07-31 | $8.71 M | 0.94% |
| 2002-07-31 | $8.63 M | -9.36% |
| 2001-07-31 | $9.52 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $3.13 B | 10,103.55% | 🇺🇸 USA |
 Becton Dickinson BDX | $0.93 B | 2,932.08% | 🇺🇸 USA |
 PerkinElmer
PKI | $2.46 B | 7,915.47% | 🇺🇸 USA |
 Bruker BRKR | $0.57 B | 1,772.01% | 🇺🇸 USA |
 NanoString Technologies NSTG | $0.11 B | 283.01% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $1.72 B | 5,528.56% | 🇺🇸 USA |